서브메뉴
검색
Key Components for Planning and Developing New Pharmaceutical Enterprises That Produce COVID-19 Vaccines in Nigeria for Local Uptake : 在尼日利亚规划和发展生产COVID-19疫苗的新制药企业的关键组成部分，以促进当地使用
Key Components for Planning and Developing New Pharmaceutical Enterprises That Produce COVID-19 Vaccines in Nigeria for Local Uptake : 在尼日利亚规划和发展生产COVID-19疫苗的新制药企业的关键组成部分，以促进当地使用
상세정보
- 자료유형
- 학위논문 서양
- 최종처리일시
- 20260202105002
- ISBN
- 9798291503713
- DDC
- 615
- 서명/저자
- Key Components for Planning and Developing New Pharmaceutical Enterprises That Produce COVID-19 Vaccines in Nigeria for Local Uptake : 在尼日利亚规划和发展生产COVID-19疫苗的新制药企业的关键组成部分，以促进当地使用
- 발행사항
- [Sl] : University of Minnesota, 2025
- 발행사항
- Ann Arbor : ProQuest Dissertations & Theses, 2025
- 형태사항
- 139 p
- 주기사항
- Source: Dissertations Abstracts International, Volume: 87-02, Section: A.
- 주기사항
- Advisor: Okoro, Olihe;Gaither, Caroline.
- 학위논문주기
- Thesis (Ph.D.)--University of Minnesota, 2025.
- 초록/해제
- 요약The COVID-19 pandemic reignited global conversations around vaccine access, underscoring the urgent need for local manufacturing capacity in low- and middle-income countries. Despite its large population and growing pharmaceutical sector, Nigeria relied entirely on imported COVID-19 vaccines. This study investigates the critical components necessary to establish a vaccine manufacturing enterprise capable of meeting domestic demand in Nigeria. A mixed-methods design was employed, combining interviews with six senior stakeholders in the regulatory and pharmaceutical sectors and a survey of 335 adults in Lagos State. Qualitative data were thematically analyzed to explore institutional, regulatory, and workforce-related barriers. Quantitative analysis assessed demographic predictors of public willingness to accept a locally produced COVID-19 vaccine. Interview participants identified core challenges including inadequate technical workforce, poor infrastructure, limited political support, and regulatory delays. Survey results showed that 76 percent of respondents would accept a Nigerian-made COVID-19 vaccine, with significantly higher acceptance among older adults and Muslim participants. Factors such as gender, employment, and educational attainment were not statistically associated with vaccine acceptance. This study contributes to ongoing discourse on regional vaccine self-reliance by offering an integrated analysis of supply-side constraints and demand-side readiness in an urban Nigerian context. These findings provide context-specific insights to support strategic planning, capacity building, and trust-building measures needed for sustainable local vaccine production.
- 일반주제명
- Pharmaceutical sciences
- 일반주제명
- Pharmacology
- 일반주제명
- Sustainability
- 키워드
- Health systems
- 키워드
- Nigeria
- 키워드
- Vaccine equity
- 기타저자
- University of Minnesota Social and Administrative Pharmacy
- 기본자료저록
- Dissertations Abstracts International. 87-02A.
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
MARC
008260126s2025 us c eng d■001000017359287
■00520260202105002
■006m o d
■007cr#unu||||||||
■020 ▼a9798291503713
■035 ▼a(MiAaPQ)AAI32167781
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a615
■1001 ▼aAremu, Taiwo Opeyemi.
■24510▼aKey Components for Planning and Developing New Pharmaceutical Enterprises That Produce COVID-19 Vaccines in Nigeria for Local Uptake ▼b在尼日利亚规划和发展生产COVID-19疫苗的新制药企业的关键组成部分，以促进当地使用
■260 ▼a[Sl]▼bUniversity of Minnesota▼c2025
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2025
■300 ▼a139 p
■500 ▼aSource: Dissertations Abstracts International, Volume: 87-02, Section: A.
■500 ▼aAdvisor: Okoro, Olihe;Gaither, Caroline.
■5021 ▼aThesis (Ph.D.)--University of Minnesota, 2025.
■520 ▼aThe COVID-19 pandemic reignited global conversations around vaccine access, underscoring the urgent need for local manufacturing capacity in low- and middle-income countries. Despite its large population and growing pharmaceutical sector, Nigeria relied entirely on imported COVID-19 vaccines. This study investigates the critical components necessary to establish a vaccine manufacturing enterprise capable of meeting domestic demand in Nigeria. A mixed-methods design was employed, combining interviews with six senior stakeholders in the regulatory and pharmaceutical sectors and a survey of 335 adults in Lagos State. Qualitative data were thematically analyzed to explore institutional, regulatory, and workforce-related barriers. Quantitative analysis assessed demographic predictors of public willingness to accept a locally produced COVID-19 vaccine. Interview participants identified core challenges including inadequate technical workforce, poor infrastructure, limited political support, and regulatory delays. Survey results showed that 76 percent of respondents would accept a Nigerian-made COVID-19 vaccine, with significantly higher acceptance among older adults and Muslim participants. Factors such as gender, employment, and educational attainment were not statistically associated with vaccine acceptance. This study contributes to ongoing discourse on regional vaccine self-reliance by offering an integrated analysis of supply-side constraints and demand-side readiness in an urban Nigerian context. These findings provide context-specific insights to support strategic planning, capacity building, and trust-building measures needed for sustainable local vaccine production.
■590 ▼aSchool code: 0130.
■650 4▼aPharmaceutical sciences
■650 4▼aPharmacology
■650 4▼aSustainability
■653 ▼aVaccine production
■653 ▼aHealth systems
■653 ▼aNigeria
■653 ▼aPharmaceutical manufacturing
■653 ▼aSustainable development goals
■653 ▼aVaccine equity
■653 ▼aCOVID-19 pandemic
■690 ▼a0572
■690 ▼a0640
■690 ▼a0419
■71020▼aUniversity of Minnesota▼bSocial and Administrative Pharmacy.
■7730 ▼tDissertations Abstracts International▼g87-02A.
■790 ▼a0130
■791 ▼aPh.D.
■792 ▼a2025
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T17359287▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
